Press Releases
-
Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat
-
Samsung Biologics Reports First Quarter 2023 Financial Results
Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2023.
Apr 23, 2023
-
CD Formulation Enhances Its Food Ingredients Lineup with Upgraded Acidity Regulators, Anticaking Agents, and Coating Agents
-
Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows
Indica Labs and Lunit has announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products.
Apr 24, 2023
-
Tower Cold Chain adds 2023 King's Award for Innovation to last year's Queen's Award
Tower Cold Chain, pharmaceutical container specialist, has been awarded the prestigious King’s Award for Enterprise, in the Innovation category – adding to the Queen’s Award for International Trade the company won in 2022.
Apr 24, 2023
-
Meridian Medical Technologies, a Kindeva Drug Delivery Company, Investing $100+ Million in Bridgeton, Missouri, Expansion
Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next four years in a newly purchased facility. Meridian, which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St. Louis area.
Apr 10, 2023
-
MDClone Synthetic Data Platform Drives Deeper Provider/Life Sciences Collaboration for Therapeutic R&D
Unique platform enables providers to securely connect life science organizations to rich patient data to test hypotheses, develop clinical trials, and create life saving therapies
Apr 11, 2023
-
Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme
Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency
Apr 10, 2023
-
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles has launched a range of reversed-phase chromatography resins with different monodisperse particle sizes.
Apr 9, 2023
-
STEMart Launches Bioburden and Sterility Testing for Medical Devices
STEMart has recently introduced the Bioburden and Sterility Testing services for medical devices.
Apr 9, 2023
-
Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research
Creative Diagnostics recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities.
Apr 9, 2023
-
PEGylation technology
PEGylation is a revolutionary modification of a therapeutic protein, nucleic acid, or small drug molecule by covalently attaching polyethylene glycol (PEG) or a derivative thereof.
Mar 31, 2023
-
BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development
BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.
Apr 12, 2023
-
BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners
In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.
Apr 6, 2023
-
CD ComputaBio Boosts Small Molecule Drug Development with Protein-Small Molecule Docking Service
-
High-Performance OLED and PLED Materials
-
Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials
Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging.
Apr 6, 2023
-
Advanced Library Amplification Mix Delivers Superior NGS Data Quality
PCR Biosystems has launched the VeriFi™ Library Amplification Mix, combining the powerful and robust proofreading performance of VeriFi™ Hot Start Polymerase with a greatly reduced GC-dependent bias.
Apr 5, 2023
-
Todaro Robotics and Abwiz Bio Celebrate Milestone
Todaro Robotics, Inc has announced a major milestone with its flagship client Abwiz Bio, Inc a company that speeds up the development of high impact monoclonal antibodies with its proprietary phage display technology. up the development of
Apr 5, 2023
-
Bora Pharmaceuticals and Celltrion partner to expand OSD capabilities in APAC market